Download PDF
CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2021; 5(01): 59-61
DOI: 10.1055/s-0041-1723095
Case Report

A Hybrid Approach for Treating Recurrent Renal Cell Carcinoma (RCC) in a Single Kidney with a Tethered Ureter

Nicole Carter 
1   Department of Radiology, Alfred Hospital, Melbourne, Victoria, Australia
,
Modher Al-Shawi
2   Department of Urology, Alfred Hospital, Melbourne, Victoria, Australia
,
Peter Royce
2   Department of Urology, Alfred Hospital, Melbourne, Victoria, Australia
3   Department of Surgery, Alfred Hospital, Melbourne, Victoria, Australia
,
Andrew O’Brien
2   Department of Urology, Alfred Hospital, Melbourne, Victoria, Australia
,
Warren Clements 
1   Department of Radiology, Alfred Hospital, Melbourne, Victoria, Australia
3   Department of Surgery, Alfred Hospital, Melbourne, Victoria, Australia
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

This case highlights a hybrid treatment model used successfully in a patient with complicated recurrent renal cell carcinoma (RCC), following partial nephrectomy, in the context of a single kidney. Scar tissue from previous surgery tethered the ureter to the margin of the lesion and combined with obesity, rendered simple percutaneous intervention challenging. The patient was ultimately successfully treated using a hybrid approach of open surgical access, ureterolysis, and intraoperative ultrasound-guided radiofrequency ablation. This approach optimized the volume of conserved normal renal parenchyma and eliminated the need for postoperative dialysis treatment, with no recurrence at 13 months follow-up.

Keywords

RCC - ablation - ureterolysis - single kidney - trauma


Publication History

Article published online:
16 March 2021

© 2021. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005; 353 (23) 2477-2490
    CrossrefPubMedGoogle Scholar
  • 2 Escudier B, Porta C, Schmidinger M. et al. ESMO Guidelines Committee. Electronic address:. clinicalguidelines@esmo.org Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019; 30 (05) 706-720
    CrossrefPubMedGoogle Scholar
  • 3 Johnson BA, Sorokin I, Cadeddu JA. Ten-year outcomes of renal tumor radio frequency ablation. J Urol 2019; 201 (02) 251-258
    CrossrefPubMedGoogle Scholar
  • 4 Uhlig J, Kokabi N, Xing M, Kim HS. Ablation versus resection for stage 1A renal cell carcinoma: national variation in clinical management and selected outcomes. Radiology 2018; 288 (03) 889-897
    CrossrefPubMedGoogle Scholar
  • 5 Cooper CJ, Teleb M, Dwivedi A. et al. Comparative outcome of computed tomography guided percutaneous radiofrequency ablation, partial nephrectomy or radical nephrectomy in the treatment of stage T1 renal cell carcinoma. Rare Tumors 2015; 7 (01) 5583
    CrossrefPubMedGoogle Scholar
  • 6 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185 (01) 64-71
    CrossrefPubMedGoogle Scholar
  • 7 MacLennan S, Imamura M, Lapitan MC. et al. UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 2012; 61 (05) 972-993
    CrossrefPubMedGoogle Scholar
  • 8 Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63 (03) 486-492
    CrossrefPubMedGoogle Scholar
  • 9 Zhou W, Herwald SE, McCarthy C, Uppot RN, Arellano RS. Radiofrequency ablation, cryoablation and microwave ablation for T1a renal cell carcinoma: A comparative evaluation of therapeutic and renal function outcomes. J Vasc Interv Radiol 2019; 30 (07) 1035-1042
    CrossrefPubMedGoogle Scholar
  • 10 Martin J, Athreya S. Meta-analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome?. Diagn Interv Radiol 2013; 19 (06) 501-507
    PubMedGoogle Scholar